SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - SPDR S&P 500 ETF Trust

Renewed tariff threats against European allies, stemming from the Greenland situation, are currently dominating market discourse for SPY and impacting futures. While some investors anticipate a significant market pullback, many view any dip as a familiar "buy the dip" opportunity, expecting a rapid recovery as markets have previously navigated similar geopolitical "drama". The community is actively debating the potential for broader trade implications and forthcoming economic and political developments to shape near-term direction.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending with high investor enthusiasm following international approvals for its Anktiva treatment in both lung and bladder cancers, notably a first-in-world non-chemo combo for lung cancer from Saudi Arabia. This significant progress, coupled with reported substantial revenue growth, is generating widespread community discussion about the company's transformative potential in oncology and fueling considerable short squeeze speculation due to high short interest. Investors are closely monitoring further global regulatory developments and anticipating a paradigm shift in cancer treatment as Dr. Patrick Soon-Shiong actively promotes the company's innovative "BioShield" platform.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is drawing considerable attention following its recent acquisition of VLX-1005, expanding its pipeline beyond a single asset, alongside ongoing progress for its flagship tecarfarin toward Phase 3 trials and manufacturing readiness. The community is actively debating its ultra-low float and the potential for tecarfarin to revolutionize anticoagulation therapy, with some analysts issuing high price targets. This discussion is set against concerns over past offerings and potential dilution, highlighting a polarized but active market interest in the microcap biotech.

Oasis is a layer-one blockchain built to support confidential applications at scale. It’s home to Sapphire, the world’s first private EVM network, Oasis Privacy Layer, a cross-chain privacy solution for any EVM dApp, and Runtime Offchain Logic, a framework that brings trustworthy off-chain computing, onchain. Powered by its ROSE token, Oasis leverages a unique layered architecture and native rollup support, making it ideal for use cases in AI, DeFi, DAOs, gaming, and more.

Oasis Network

Oasis Network (ROSE) is trending amidst a strong pivot towards AI and privacy, highlighted by a recent rebrand and ongoing developments leveraging Trusted Execution Environments for secure data. The community is actively discussing its potential as an undervalued asset, anticipating significant growth within the booming privacy and AI crypto sectors. This positions ROSE as a key contender addressing critical demands for data security in Web3.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as renewed tariff threats regarding Greenland trigger market volatility, with the community sharply divided between those anticipating a significant correction and "buy the dip" proponents. Investors are weighing escalating geopolitical tensions and rising treasury yields against historical market resilience and expectations for a robust tech earnings season.

America's Oil Reserve for the Digital Age

U.S Oil

USOR CRYPTO is trending due to significant community interest in acquiring the newly launched token, which has seen rapid growth in market capitalization and holder count. However, conversation is actively shaped by user confusion and reported discrepancies concerning its availability and pricing on platforms like Coinbase, alongside a debate between optimistic growth predictions and concerns over its legitimacy.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin (APP) is experiencing significant recent volatility and a notable pullback, sparking intense community debate. While bulls highlight strong fundamental growth from its AI-powered AXON platform and recent analyst upgrades as a "buy the dip" opportunity, bears point to circulating short report rumors and broader ad-tech sector weakness, alongside discussions of options market dynamics, as reasons for the sharp decline. This creates a highly active discussion about the stock's near-term direction ahead of upcoming earnings.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Shares of Trump Media & Technology Group are trending as recent statements from Donald Trump regarding Greenland's acquisition and associated tariff threats on European nations spark intense debate. The community is actively discussing the geopolitical implications and potential market volatility, with sentiment largely driven by reactions to these prominent political headlines.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is currently trending due to significant activity on its Etherlink L2, including a 'Uranium Tokenization Breakthrough' that garnered a fintech innovation award and substantial growth in transactions and deployed contracts. Community sentiment is sharply divided, with discussions highlighting expanded staking accessibility and Tezos's role in the Real World Asset (RWA) narrative, while a vocal segment anticipates further price declines amidst broader altcoin market volatility.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares

LABD is trending as the S&P Biotech Select Industry Index (XBI) shows unusual resilience and continued bullish momentum, leading to significant frustration among investors anticipating a sector pullback. Despite widespread calls for a reversal based on technical divergences and broader economic concerns, XBI's strength, potentially fueled by M&A and market rotation, has left many "bag holding" this inverse ETF while keenly debating future entry opportunities.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

How to Find the Best Value Stock Screens for 2026

Avoid value traps in 2026. Buy value stocks that have earnings growth.

Redwood Trust Announces Fourth Quarter 2025 Common and Preferred Dividends

Redwood Trust, Inc. (NYSE: RWT; Redwood or the Company), a leader in expanding access to housing for homebuyers and renters, today announced that its Board of Directors (the Board) has declared...

Redwood Trust Prices $100 Million Senior Notes Offering

Redwood Trust, Inc. (NYSE: RWT; Redwood or the Company) today announced the pricing of an underwritten public offering of $100,000,000 aggregate principal amount of its 9.50% senior notes due 2030...

Redwood Trust (RWT) Loses 11.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Redwood Trust (RWT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Here's What Key Metrics Tell Us About Redwood Trust (RWT) Q3 Earnings

The headline numbers for Redwood Trust (RWT) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Redwood Trust (RWT) Beats Q3 Earnings Estimates

Redwood Trust (RWT) delivered earnings and revenue surprises of +25.00% and -50.02%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Redwood Trust Reports Third Quarter 2025 Financial Results; Record Production Volumes Advance Transition to Core Operating Model

Redwood Trust, Inc. (NYSE:RWT; 'Redwood', the 'Company'), a leader in expanding access to housing for homebuyers and renters, today reported its financial results for the quarter ended September 30...

Earnings Preview: Apollo Commerical Finance (ARI) Q3 Earnings Expected to Decline

Apollo Commerical Finance (ARI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Redwood Trust Announces Date of Third Quarter 2025 Financial Results Webcast and Conference Call

Redwood Trust, Inc. (NYSE: RWT; Redwood or the Company), a leader in expanding access to housing for homebuyers and renters, is scheduled to release its third quarter 2025 results on Wednesday...

Is the Options Market Predicting a Spike in Redwood Trust Stock?

Investors need to pay close attention to RWT stock based on the movements in the options market lately.

Redwood Trust, Inc. is a financial company, which focuses on several distinct areas of housing credit. It operates through the following segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, and Redwood Investments. The Sequoia Mortgage Banking segment consists of a mortgage loan conduit that acquires residential loans from third-party originators for subsequent sale, securitization, or transfer into the investment portfolio. The CoreVest Mortgage Banking segment includes the platform that originates and acquires business purpose residential loans. The Redwood Investments segment covers the organic investments sourced through the residential and business purpose mortgage banking operations. The company was founded by George E. Bull III, Douglas B. Hansen and Frederick H. Borden on April 11, 1994 and is headquartered in Mill Valley, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	$0.15	--	--	N/A
Q3 '25	$0.17	-$0.08	-147.04%	MISSED
Q2 '25	$0.17	-$0.76	-557.59%	MISSED
Q1 '25	$0.15	$0.10	-33.14%	MISSED
Q4 '24	$0.10	-$0.07	-169.84%	MISSED

RWT
Redwood Trust Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest RWT News

RWTRedwood Trust Inc.